Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: Lack of correlation between inhibition of cell growth and MAP kinase activation

Author(s):  
Robert Wieder ◽  
Eyal Fenig ◽  
Huisheng Wang ◽  
Qin Wang ◽  
Shoshana Paglin ◽  
...  
FEBS Letters ◽  
2000 ◽  
Vol 478 (3) ◽  
pp. 209-215 ◽  
Author(s):  
Anne-Sophie Vercoutter-Edouart ◽  
Jérôme Lemoine ◽  
Chanel E. Smart ◽  
Victor Nurcombe ◽  
Bénoni Boilly ◽  
...  

1994 ◽  
Vol 225 (3) ◽  
pp. 1041-1046 ◽  
Author(s):  
Sadakazu Miyashita ◽  
Masao Hirota ◽  
Toshiya Yamamoto ◽  
Chiyoka Shiroyama ◽  
Yoshiko Furukawa ◽  
...  

2001 ◽  
Vol 262 (1) ◽  
pp. 59-68 ◽  
Author(s):  
Anne-Sophie Vercoutter-Edouart ◽  
Xavier Czeszak ◽  
Michel Crépin ◽  
Jérôme Lemoine ◽  
Bénoni Boilly ◽  
...  

2003 ◽  
Vol 17 (10) ◽  
pp. 2002-2012 ◽  
Author(s):  
Olga A. Sukocheva ◽  
Lijun Wang ◽  
Nathaniel Albanese ◽  
Stuart M. Pitson ◽  
Mathew A. Vadas ◽  
...  

Abstract Current understanding of cytoplasmic signaling pathways that mediate estrogen action in human breast cancer is incomplete. Here we report that treatment with 17β-estradiol (E2) activates a novel signaling pathway via activation of sphingosine kinase (SphK) in MCF-7 breast cancer cells. We found that E2 has dual actions to stimulate SphK activity, i.e. a rapid and transient activation mediated by putative membrane G protein-coupled estrogen receptors (ER) and a delayed but prolonged activation relying on the transcriptional activity of ER. The E2-induced SphK activity consequently activates downstream signal cascades including intracellular Ca2+ mobilization and Erk1/2 activation. Enforced expression of human SphK type 1 gene in MCF-7 cells resulted in increases in SphK activity and cell growth. Moreover, the E2-dependent mitogenesis were highly promoted by SphK overexpression as determined by colony growth in soft agar and solid focus formation. In contrast, expression of SphKG82D, a dominant-negative mutant SphK, profoundly inhibited the E2-mediated Ca2+ mobilization, Erk1/2 activity and neoplastic cell growth. Thus, our data suggest that SphK activation is an important cytoplasmic signaling to transduce estrogen-dependent mitogenic and carcinogenic action in human breast cancer cells.


2000 ◽  
Vol 273 (2) ◽  
pp. 675-680 ◽  
Author(s):  
Alex Lyakhovich ◽  
Nickolai Aksenov ◽  
Pasi Pennanen ◽  
Susanna Miettinen ◽  
Merja H. Ahonen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document